DOAC-Remove™250
Product No. 5D-82410C · Size: 250 tablets
Auxiliary Reagents » Other Auxiliary Reagents 
Description
DOAC-RemoveTM tablets are intended to be used for removal of Direct Oral Anticoagulant (DOAC) compounds from human citrated plasma samples, including dabigatran, rivaroxaban, apixaban and edoxaban. Also removes argatroban. DOAC-RemoveTM has no significant effect on clotting factors.
Intended use
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
Related Products
Name
Insert
MSDS